{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:08:56Z","timestamp":1744178936411},"reference-count":14,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T00:00:00Z","timestamp":1430784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0123554","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T17:50:07Z","timestamp":1430848207000},"page":"e0123554","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients"],"prefix":"10.1371","volume":"10","author":[{"given":"Jong Man","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Choon Hyuck David","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Won","family":"Joh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Eun","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Hyun","family":"Sinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyu-Seong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyong Ran","family":"Peck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk-Koo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/CMR.00015-13","article-title":"Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation","volume":"26","author":"RR Razonable","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4254\/wjh.v6.i6.370","article-title":"Management of cytomegalovirus infection and disease in liver transplant recipients","volume":"6","author":"J Bruminhent","year":"2014","journal-title":"World J Hepatol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/lt.22249","article-title":"Is cytomegalovirus infection dangerous in cytomegalovirus-seropositive recipients after liver transplantation?","volume":"17","author":"JM Kim","year":"2011","journal-title":"Liver Transpl"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/apt.12305","article-title":"Systematic review: macrophage activation syndrome in inflammatory bowel disease","volume":"37","author":"W Fries","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.trre.2014.01.001","article-title":"The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients","volume":"28","author":"A Roman","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.3748\/wjg.v20.i31.10658","article-title":"Cytomegalovirus infection in liver transplant recipients: updates on clinical management","volume":"20","author":"JR Marcelin","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/AAC.44.10.2811-2815.2000","article-title":"Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients","volume":"44","author":"MD Pescovitz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/01.TP.0000146844.65273.62","article-title":"Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease","volume":"79","author":"N Singh","year":"2005","journal-title":"Transplantation"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/135965350501000109","article-title":"Similar reduction of cytomegalovirus DNA load by oral valganciclovir and intravenous ganciclovir on pre-emptive therapy after renal and renal-pancreas transplantation","volume":"10","author":"JS Kalpoe","year":"2005","journal-title":"Antivir Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/TP.0b013e31828ee12e","article-title":"International survey of cytomegalovirus management in solid organ transplantation after the publication of consensus guidelines","volume":"95","author":"AK Le Page","year":"2013","journal-title":"Transplantation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1111\/j.1600-6143.2007.01910.x","article-title":"Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients","volume":"7","author":"A Asberg","year":"2007","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"ref12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"RR Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/lt.23530","article-title":"Risk of cytomegalovirus disease in high-risk liver transplant recipients on valganciclovir prophylaxis: a systematic review and meta-analysis","volume":"18","author":"AC Kalil","year":"2012","journal-title":"Liver Transpl"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e5512","DOI":"10.1371\/journal.pone.0005512","article-title":"Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy","volume":"4","author":"AC Kalil","year":"2009","journal-title":"PLoS One"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0123554","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T06:56:43Z","timestamp":1651906603000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0123554"}},"subtitle":[],"editor":[{"given":"Kwan","family":"Man","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,5]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0123554","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,5]]}}}